Actinium Pharmaceuticals, Inc. (ATNM)
1.20
+0.02
(+1.69%)
USD |
NYAM |
Mar 06, 16:00
1.19
-0.01
(-0.83%)
After-Hours: 20:00
Actinium Pharmaceuticals SG&A Expense (TTM) : 15.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| Altimmune, Inc. | 28.10M |
| Aldeyra Therapeutics, Inc. | 9.602M |
| Avanos Medical, Inc. | 315.60M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |